Functional outcome of autologus platelet rich plasma injection as treatment for patients with plantar fascitis

Authors

  • Sandesh F. Akki Department of Orthopaedic, SDM University, Sattur, Dharwad, Karnataka, India
  • Nandakishore Bhat Department of Orthopaedic, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
  • Akshay H. Department of Orthopaedic, Mandya Institute of Medical Sciences, Mandya, Karnataka, India
  • Akshata N. Department of ENT, SDM University, Sattur, Dharwad, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20242387

Keywords:

Plantar fascitis, Platelet-rich plasma, Autologous PRP injection

Abstract

Background: Plantar fasciitis (PF) is the most common cause of pain that occurs in the heel, and approximately 11% to 15% of adults having foot symptoms require an expert care. Heel pain and tenderness are some of the common symptoms. Many conservatives methods are available, Platelet rich plasma is one of the safe and effective therapy in relieving symptoms. To describe the functional outcome of autologus platelet rich plasma as treatment for patients with plantar fasciitis. To describe any complications associated with the procedure.

Methods: It is a prospective observational study 45 patients with chronic Plantar fasciitis aged above 18 years were included in the study. All the patients had a minimum of 3 months of symptoms, were selected based on the inclusion and exclusion criteria and underwent the same method of treatment. All patients had a baseline assessment of numerical pain score and were repeated at regular intervals post treatment. The PRP was prepared from venous whole blood.

Results: Pain score was assessed at the time of injection. The mean pain score of all the patients was 8.614. Percentage pain relief showed 48% had 100% pain relief, 33% had more than 50% pain relief and 6% had less than 50% pain relief from the study.

Conclusion: Autologous PRP injection is a safe and useful modality of treatment in the treatment of Plantar fasciitis. Maximum benefit after PRP injection was observed at 2 months and had sustained for at least 6 months.

References

Schwartz EN, Su J. Plantar fasciitis: a concise review. Perm J. 2014;18(1):105.

Paramasivam M, Thamizharasan K, Sambandam M. A prospective study on use of platelet rich plasma for treatment of plantar fasciitis. Int J Orthop. 2017;3(3):313-6.

Buchbinder R. Clinical practice. Plantar fasciitis. N Engl J Med. 2004;350:2159-66.

Taunton JE, Ryan MB, Clement DB, McKenzie DC, Lloyd-Smith DR, Zumbo BD. A retrospective case-control analysis of 2002 running injuries. BJSM. 2002;36(2):95-101.

Dastgir N. Extracorporeal shock wave therapy for treatment of plantar fasciitis. J Pak Med Assoc. 2014;64:675-8.

Salvi AE. Targeting the plantar fascia for corticosteroid injection. J Foot Ankle Surg. 2015;54(4):683-5.

Johnson RE, Haas K, Lindow K, Shields R. Plantar fasciitis: what is the diagnosis and treatment? Orthop Nurs. 2014;33(4):198-204.

Porter MD, Shadbolt B. Intralesional corticosteroid injection versus extracorporeal shock wave therapy for plantar fasciopathy. J Foot Ankle Surg. 2005;15(3):119-24.

Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. American family physician. 2011;84(6):676-82.

Ogden JA, Alvarez RG, Marlow M. Shockwave therapy for chronic proximal plantar fasciitis: a meta-analysis. J Foot Ankle Surg. 2002;23(4):301-8.

Wei LC, Lei GH, Sheng PY, Gao SG, Xu M, Jiang W, et al. Efficacy of platelet‐rich plasma combined with allograft bone in the management of displaced intra‐articular calcaneal fractures: A prospective cohort study.JORT. 2012;30(10):1570-6.

Marx RE. Platelet-rich plasma: evidence to support its use. JOMS. 2004;62(4):489-96.

Mohamed E, Ragab S, Mohamed A, Othman A. Platelet rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg. 2012;132:1065-70.

Akşahin E, Doğruyol D, Yüksel HY, Hapa O, Doğan Ö, Çelebi L, et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2012;132:781-5.

Mazzocca AD, Mccarthy MBR, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, et al. Platelet-rich plasma differs according to preparation method and

human variability. J Bone Jt Surg. 2012;94:308-16.

Yang WY, Han YH, Cao XW, Pan JK, Zeng LF, Lin JT, et al. Platelet-rich plasma as a treatment for plantar fasciitis: A meta-analysis of randomized controlled trials. Medicine. 2017;96(44):8475.

Bezwada S, Khare T, Ramamurthy BD, Devisriprasad S. Role of platelet rich plasma in the management of plantar fasciitis: a prospective interventional study. JCDR. 2022;16:14-8.

Downloads

Published

2024-08-28

Issue

Section

Original Research Articles